Market Tracker

11/21 6:05pm ET

Alimera Sciences Inc (NASDAQ:ALIM)

5.37
Data as of Nov 21
 -0.06 / -1.10%
Today’s Change
1.94
Today|||52-Week Range
8.44
+14.26%
Year-to-Date
No recent news for Alimera Sciences Inc.

Today’s Trading

Previous close5.43
Today’s open5.50
Day’s range5.31 - 5.56
Volume130,514
Average volume (3 months)385,402
Market cap$237.9M
Dividend yield--
Data as of 3:59pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)-157.14%
Earnings growth (this year)+25.24%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales79.29
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CNCEConcert Pharmaceutic...+0.09+0.70%
HRTXHeron Therapeutics I...+0.16+2.03%
GALEGalena Biopharma Inc+0.21+11.29%
ADMSAdamas Pharmaceutica...+0.10+0.68%
Data as of 3:59pm ET, 11/21/2014

Financials

Next reporting dateFebruary 26, 2015
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$1.9M
Annual profit (last year)-$51.2M
Net profit margin-2,733.92%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Charles Daniel Myers
Secretary, Chief Operating &
Financial Officer
Richard S. Eiswirth
Corporate headquarters
Alpharetta, Georgia

Forecasts